Podcasts

Gladell Paner, MD, FCAP, speaks with Raja Seethala, MD, FCAP, and Nicole Cipriani, MD, FCAP, surgical pathologists specializing in head and neck pathology and members of the CAP Cancer Committee.

We’ll speak with Dr. Andres Romero about the Conrad 30 waiver program We’ll also review a boost to Medicare pay in the new spending bill, a hearing on LDTs, and more.

Three previous recipients of CAP Foundation grants and awards discuss the impact of the awards on their careers in pathology and involvement in the CAP.

In this episode, Gladell Paner, MD, FCAP, talks with gastrointestinal pathologists Dhanpat Jain, MD, FCAP, and Adam Booth, MD, FCAP, about how the CAP Biomarker Reporting Protocols were developed and used in practice.

This month we’ll look at the historic benchmarks earned by the CAP’s Pathologists Quality Registry, advocacy wins and strides in the private sector, changes to an FDA reclassification process and more. We'll also speak with Matthew Foster MD, FCAP, about Hill Day at the 2024 Pathologists Leadership Summit, key policy requests, and why it's important for CAP members to get involved.

To commemorate World Cancer Day, Gladell Paner, MD, FCAP, chatted with M.E. de Baca, MD, FCAP, and Gail Vance, MD, FCAP, about how the CAP is addressing barriers to health equity through the Cancer Protocols, Council on Informatics and Pathology Innovation, and the CAP Foundation Global Pathology Committee.

This month we'll look at a prior authorization rule that could pave the way for legislation to reduce burdens on clinicians, a grant awarded to the CAP to improve healthcare communication, action on Medicare cuts, and more. We'll also sit down with Anna Tart, MD, FCAP, to talk about why the CAP no longer supports 'excited delirium' as an official cause of death.

Dr. Jason Scapa, Chair of the Digital Content Committee, talks with Dr. Andrew Bellizzi, Past Chair of the Immunohistochemistry (IHC) Committee, and current IHC Committee Member Dr. Gregory Bean about the latest update to HER2 Breast Cancer Testing Guidelines.

This month we'll take a look at efforts to mitigate recent Medicare cuts, digital and cybersecurity news in the health care sector, and more.

So you have a job offer. Now what? If you're a senior trainee or new-in-practice pathologist navigating contract negotiation for the first time, this episode is for you.

Jim Vaught, PhD, Editor Emeritus of the Biopreservation and Biobanking journal, joins the podcast to talk about the new era we are entering where new markets and technologies will result in new approaches to collecting, processing, and storing samples.

Joseph Sirintrapun, MD, FCAP, and Dibson Gondim, MD, FCAP discuss implementing digital pathology at UofL Health.

This month we'll review the 2024 Final Medicare Physician Fee Schedule and what it means to you as well as a grant for the CAP's work to promote effective communication in health care. We will also sit down with Dr. Mark Synovec to discuss what happened at the most recent AMA meeting and what it means going forward.

Experts in cancer research discuss how the CAP’s Cancer Protocols are created and used, the difference between Cancer Protocols and electronic Cancer Protocols, and the future of synoptic reporting.

Interviewing for your first job as a pathologist might seem intimidating. But this is an opportunity to not only showcase your abilities but to find out if the position and practice setting are a good fit for you and your career goals.

In this special CAPcast episode, CAP Foundation President Eva M. Wojcik, MD, FCAP, talks with CAP Foundation board member Sara Herbek, Esq, and CAP Board member Diana Cardona, MD, FCAP. They share their personal connections to the CAP Foundation and discuss advocating for your own personal health and the work the Foundation is doing for pathologists and patients.

As leaders in the medical laboratory, pathologists are important gatekeepers to the highest value use of ancillary testing techniques for patient samples. So, how can a pathologist prepare for questions on molecular tests before they come? In this episode, Jennifer Yoest, MD, FCAP, author of the new Clinical Pathology Improvement Program case Choosing a Molecular Test: Techniques Decoded, shares her thoughts.

The liquid biopsy has rapidly emerged as a method to minimize the amount of tissue needed for testing, making it a less invasive and safer alternative to more traditional procedures. As it continues to evolve, liquid biopsies offer exciting new options in the practice of pathology. In this episode, Maria Arcila, MD, FCAP, and JinJuan Yao, MD, FCAP, discuss the development of this new diagnostic tool.

We sat down with the newly inaugurated CAP President Dr. Donald Karcher to discuss the CAP's legislative priorities and how advocacy by CAP members can advance the profession.

In this CAPcast, Mary Edgerton, MD, FCAP, talks with experts in pancreatic cancer research, diagnosis, treatment, and patient advocacy.